Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 381
Appendix J
Biosketches of Committee
Members and Staff
Charles P. O’Brien, M.D., Ph.D. (Chair), is Kenneth E. Appel professor and
vice chair of psychiatry at the University of Pennsylvania and director of the
Center for Studies of Addiction. Dr. O’Brien’s work involves the discovery
of central nervous system changes involved in relapse, new medications
for addiction, behavioral treatments, and instruments for measuring the
severity of addictive disorders. He led the discovery of the effects of alcohol
on the endogenous opioid system and developed a completely new treat-
ment for alcoholism. Many of his discoveries are now utilized in common
practice for the treatment of addictive disorders throughout the world. Dr.
O’Brien was elected to the Institute of Medicine (IOM) of the National
Academies in 1991 and has received numerous national research awards, as
well as an honorary doctorate from the University of Bordeaux in 1994. He
received the Nathan B. Eddy award for research on addiction from the Col-
lege on Problems of Drug Dependence in 2003, the American Psychological
Association (APA) Research Award for 2000, the 2010 Gold Medal for
Research from the Society on Biological Psychiatry, the 2010 Sarnat Award
from the Institute of Medicine for Mental Health Research, and the 2012
Jellinek award for research on alcoholism. He has been an adviser on drug
policy to local and national governments since the 1970s and has chaired
or served as a member of numerous IOM committees dealing with the sci-
ence and policy of abused drugs. He is currently chair of the substance use
disorders committee for the Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5). Dr. O’Brien is past president of the
American College of Neuropsychopharmacology and the Association for
Research in Nervous and Mental Disease. He earned his M.D. and Ph.D.
381
OCR for page 382
382 SUBSTANCE USE DISORDERS IN THE U.S. ARMED FORCES
degrees from Tulane University. He received residency training at Harvard,
Tulane, the University of London, and the University of Pennsylvania in
internal medicine, neurology, and psychiatry and is board certified in both
neurology and psychiatry.
Hortensia D. Amaro, Ph.D., is associate vice provost for community research
initiatives and dean’s professor of social work and preventive medicine at
the University of Southern California. For the past 10 years, she served as
associate dean and distinguished professor of health sciences and of counsel-
ing psychology in the Bouve College of Health Sciences, and director of the
Institute on Urban Health Research at Northeastern University. Her research
has focused on alcohol and drug use and addiction among adolescents and
adults, the development and testing of behavioral interventions for HIV/
AIDS prevention, substance abuse and mental health treatment for Latinos
and African Americans, alcohol and drug use among college populations,
behavioral interventions for adherence to HIV medications, and integration
of behavioral health care into the pediatric medical home. She has authored
more than 135 publications on these topics. Dr. Amaro has served on the
editorial boards of the American Psychologist, American Journal of Public
Health, Cultural Diversity and Ethnic Minority Psychology, and other lead-
ing publications. She was elected to the IOM of the National Academies
in 2011 and has received numerous awards from professional, government
and community organizations and honorary degrees from Simmons College
and the Massachusetts School of Professional Psychology. Additionally, she
has served on review and advisory committees for the National Institutes
of Health (NIH), the U.S. Department of Health and Human Services, the
Substance Abuse and Mental Health Services Administration, and the Cen-
ters for Disease Control and Prevention. Dr. Amaro founded five substance
abuse treatment programs for women in Boston and served on the board of
the Boston Public Health Commission for 14 years. She received her B.A.,
M.A., and Ph.D. degrees in psychology from the University of California,
Los Angeles.
Rhonda Robinson Beale, M.D., is chief medical officer for OptumHealth
Behavioral Solutions, a leading provider of solutions for mental health and
substance use disorders in California. Dr. Robinson Beale develops qual-
ity initiatives and clinical systems for OptumHealth Behavioral Solutions.
She has more than 20 years of experience in behavioral health and quality
management and is an active member of the behavioral health community.
Dr. Robinson Beale has been involved with the National Committee for
Quality Assurance as a surveyor; a member of the Review Oversite Com-
mittee, which makes accreditation decisions; and a member of advisory
panels that developed the managed behavioral health care organization
OCR for page 383
APPENDIX J 383
(MBHO) and disease management standards. She has also been a member
of the board of directors for the IOM’s Neuroscience and Behavioral Health
and Health Care Services Boards and has served on several IOM commit-
tees. Dr. Robinson Beale participated on the National Quality Forum’s
board of directors as co-chair for the Evidence-Based Practices to Treat
Substance Use Disorders Steering Committee. Before joining OptumHealth
Behavioral Solutions, she was chief medical officer for PacifiCare Behavioral
Health. She also served as senior vice president and chief medical officer for
CIGNA Behavioral Health, national medical director for Blue Cross Blue
Shield, executive medical director of medical and care management clinical
programs for Blue Cross Blue Shield of Michigan, and senior medical direc-
tor for behavioral medicine for Health Alliance Plan. Dr. Robinson Beale
received her medical degree from Wayne State University and her psychiat-
ric training at Detroit Psychiatric Institute. She is certified in psychiatry by
the American Board of Psychiatry and Neurology.
Robert M. Bray, Ph.D., a fellow of the APA, is a senior research psy-
chologist and director of the Substance Abuse Epidemiology and Military
Behavioral Health Program at RTI International. His research interests
focus on the epidemiology of substance use and other health behaviors in
military and civilian populations, with an emphasis on understanding the
prevalence, causes, correlates, and consequences of these behaviors. He
has directed nine comprehensive worldwide Department of Defense health
behavior surveys of active duty military personnel that have furnished the
most widely cited data on substance use and health behaviors in the military
and is preparing a book summarizing findings from these studies. He has
directed and supported other studies in the military assessing health-related
behaviors among the reserve component, risk and protective factors for
initiation of tobacco and alcohol use, mental fitness and resilience among
Army basic trainees, and a Web-based intervention to reduce heavy alcohol
use. He is currently leading the RTI component of a large multi-institutional
clinical trial to optimize usual primary care for soldiers with posttraumatic
stress disorder and depression. Dr. Bray is principal editor of Drug Use in
Metropolitan America, which integrates findings from a large-scale study
of drug use among diverse populations in the Washington, DC, metropoli-
tan area. He has published and presented widely in the area of substance
use– and health-related behaviors. Dr. Bray previously served on an IOM
committee examining drug use in the workplace. He received his Ph.D.
in social psychology from the University of Illinois and his M.S. and A.B.
degrees in psychology from Brigham Young University.
Raul Caetano, M.D., Ph.D., is regional dean and professor of epidemiology
at the Dallas Regional Campus of the University of Texas School of Public
OCR for page 384
384 SUBSTANCE USE DISORDERS IN THE U.S. ARMED FORCES
Health. He also is dean and professor of health care sciences and psychia-
try at the School of Health Professions, University of Texas Southwestern
Medical Center, in Dallas. His area of expertise is the epidemiology of
substance use by minorities, including studies of the association between
intimate partner violence and substance use. He is well published in this
area and also serves on the editorial boards of many substance abuse jour-
nals. Dr. Caetano also serves on the advisory boards for several substance
abuse agencies in his community. Before coming to the University of Texas
system in 1998, he was a senior scientist and director of the California-
based Alcohol Research Group, a National Alcohol Research Center funded
by the National Institute on Alcohol Abuse and Alcoholism. He previously
served on an IOM committee that examined coverage for substance abuse
treatment. Dr. Caetano earned his M.D. in psychiatry from the State Uni-
versity of Rio de Janeiro in Brazil. From 1973 to 1974 he was at the Lon-
don School of Hygiene and Tropical Medicine, and from 1973 to 1976 he
was a research psychiatrist at the Institute of Psychiatry of the University of
London in England. He also earned an M.P.H. in behavioral sciences and
a Ph.D. in epidemiology, both from the School of Public Health, University
of California, Berkeley.
Mathea Falco, J.D., is president of Drug Strategies, a nonprofit research
institute in Washington, DC, established in 1992, that promotes more
effective approaches to the nation’s drug problems. She is a visiting scholar
at the Harvard Law School Center for International Criminal Justice and
was a fellow at Harvard’s Weatherhead Center for International Affairs, as
well as associate professor of public health, Weill Medical College/Cornell
University, in New York City. The author of The Making of a Drug Free
America: Programs That Work (Times Books, 1994), as well as numerous
articles, Ms. Falco comments frequently on drug policy in the media and in
public speeches across the country. Until 1993, she was director of health
policy, Department of Public Health, Cornell University Medical College,
in New York City. From 1977 to 1981, Ms. Falco was assistant secretary
of state for International Narcotics Matters. Earlier, she served as chief
counsel and staff director for the U.S. Senate Judiciary Committee’s Juvenile
Delinquency Subcommittee, special assistant to the president of the Drug
Abuse Council, and senior associate of the Carnegie Endowment for Inter-
national Peace. Ms. Falco received her B.A. from Radcliffe College and her
J.D. from Yale Law School.
Joyce M. Johnson, D.O., M.A., is vice president of health sciences and
chief medical officer in Battelle’s Health and Life Sciences Global Business,
located in Arlington, Virginia. She joined Battelle in December 2003 upon
her retirement from the U.S. Public Health Service (Rear Admiral, Upper
OCR for page 385
APPENDIX J 385
Half). She had been assigned to the U.S. Coast Guard, Department of
Homeland Security, as chief medical officer/director, health and safety, and
functioned as the Coast Guard’s surgeon general. Her other government
assignments included senior scientific and management positions with the
Food and Drug Administration and the Substance Abuse and Mental Health
Services Administration. She has held clinical positions at the National
Institute of Mental Health and the VA. At the Centers for Disease Control
and Prevention, she was an Epidemiologic Intelligence Service officer and
staff epidemiologist in the Center for Infectious Disease. Dr. Johnson is a
physician board certified in three specialties—public health and preventive
medicine, clinical pharmacology, and psychiatry. In addition to her medical
degree, she earned a master’s degree in hospital and health administration
and has received five honorary doctoral degrees. She is a certified addic-
tion specialist and certified food service executive. Dr. Johnson earned her
bachelor’s degree from Luther College, her master’s degree in hospital and
health administration from the University of Iowa, and her medical degree
from Michigan State University.
Thomas Kosten, M.D., is the J.H. Waggoner chair and professor of psychi
atry, pharmacology, and neuroscience, Baylor College of Medicine, and
former professor and chief of psychiatry at Yale University and the VA in
Connecticut. He is research director of the VA National Substance Use Dis-
orders Quality Enhancement Research Initiative, based in Houston, Texas.
Dr. Kosten is founder of the Division of Substance Abuse at Baylor and
Yale and directs their NIH Medications Development Center for substance
abuse. He has been supported by a Research Scientist Award from NIH
since 1987 and has served on national and international review groups for
medications development in substance abuse. Dr. Kosten has been a con-
gressional fellow in the House of Representatives and a visiting professor
in Canada, China, Germany, Greece, and Spain. He is founding vice chair
for Added Qualifications in Addiction Psychiatry of the American Board
of Psychiatry and Neurology, a distinguished fellow in the APA, a fellow
of the American College of Neuropsychopharmacology, and past president
of both the American Academy of Addiction Psychiatry and the College on
Problems of Drug Dependence. Dr. Kosten received his B.S. from the Rens-
selaer Polytechnic Institute, his M.A. from Yale, and his M.D. from Cornell
University Medical College.
Mary Jo Larson, Ph.D., is senior scientist at the Institute for Behavioral
Health, Schneider Institutes for Health Policy, Heller School for Social Pol-
icy and Management, Brandeis University. She is a health services researcher
specializing in access to and quality and cost of care delivered in mental
health and substance abuse service delivery systems. She also has expertise
OCR for page 386
386 SUBSTANCE USE DISORDERS IN THE U.S. ARMED FORCES
in the military health care system and the impact of the Operation Iraqi
Freedom and Operation Enduring Freedom conflicts on military families.
With funding from the National Institute on Drug Abuse, she is conducting
a study on recent combat veterans using longitudinal military health care
data. Dr. Larson has conducted primary data collection studies on the out-
comes of care in community-based detoxification programs and outpatient
addiction programs within managed care and public systems, outcomes
of integrated services for comorbid disorders for women with trauma and
posttraumatic stress disorder, and other studies of service delivery systems
for populations that are disenfranchised or experiencing chronic homeless-
ness or incarceration. She has conducted secondary data analysis projects
(Medicaid, Medicare, National Endangered Species Act Reform Coalition
[NESARC]), including studies that merged large public-sector databases.
Dr. Larson received her Ph.D. from The Heller School at Brandeis Uni-
versity, her M.P.A. from the John F. Kennedy School of Government at
Harvard University, and her B.A. in psychology from the University of
Minnesota.
David C. Lewis, M.D., is professor emeritus of community health and
medicine and Donald G. Millar emeritus distinguished professor of alcohol
and addiction studies at Brown University. In 1982 he founded and for 18
years he directed the Brown University Center for Alcohol and Addiction
Studies. Dr. Lewis is a graduate of Brown University and Harvard Medical
School. Trained in internal medicine, he is a fellow of the American College
of Physicians. He has been a member of several boards of directors, includ-
ing those of the National Council on Alcoholism and Drug Dependence
(where he was chairman of the board), the American Society of Addiction
Medicine, the Drug Policy Alliance, the Veterans Healing Initiative and the
Association for Medical Education and Research in Substance Abuse. He
is the founder of Physician Leadership on National Drug Policy (PLNDP)
and now serves on the board of directors of the new PLNDP—Physicians
and Lawyers for National Drug Policy. Dr. Lewis has an international
reputation for his work on substance abuse treatment, medical education,
and public policy.
Dennis McCarty, Ph.D., is professor in the Department of Public Health and
Preventive Medicine at Oregon Health & Science University in Portland,
Oregon, and co–principal investigator for the Western States Node of the
National Drug Abuse Treatment Clinical Trials Network. Dr. McCarty
collaborates with policy makers in state and federal government and with
community-based programs to conduct studies that examine the organiza-
tion, financing, and delivery of substance abuse treatment services. Between
1989 and 1995, Dr. McCarty served as director of the Massachusetts
OCR for page 387
APPENDIX J 387
Bureau of Substance Abuse Services for the Massachusetts Department of
Public Health. He currently serves on Oregon’s Alcohol and Drug Policy
Commission. Dr. McCarty served on two prior IOM committees and was
a co-editor for both committee reports: Managing Managed Care: Quality
Improvement in Behavioral Health Care and Bridging the Gap Between
Practice and Research: Forging Partnerships with Community-Based Drug
and Alcohol Treatment. He received his B.A. degree in psychology and
his M.A. and Ph.D. degrees in social psychology from the University of
Kentucky. In 2007, he was named a fellow in the APA. He is a member of
the editorial boards for the Journal of Substance Abuse Treatment and the
Journal of Behavioral Health Services and Research.
Mary Ann Pentz, Ph.D., is professor of preventive medicine and director of
the Institute for Health Promotion and Disease Prevention Research at the
University of Southern California. Her research focuses on community and
policy approaches to tobacco, alcohol, and drug abuse prevention in youth.
She is widely published in psychology, public health, and medical journals
on the use of multicomponent approaches to community-based prevention
that include mass media. The findings from her longitudinal prevention
trials contributed to the formulation of a U.S. Senate bill, as well as the
use of evidence-based criteria for appropriating funds for prevention under
the Safe and Drug Free Schools Act, for which she provided U.S. congres-
sional testimony sponsored by Senator Kennedy. Dr. Pentz has chaired the
National Institute on Drug Abuse Epidemiology and Prevention study sec-
tion. She has served on the evaluation advisory boards for the Center for
Substance Abuse Prevention’s Community Partnership grants program and
the Robert Wood Johnson Foundation’s Fighting Back Initiative; on the
Office of National Drug Control Policy’s Campaign Design expert panel,
tasked to design the new anti-drug abuse media campaigns; on the U.S.A.
Horn General’s Methamphetamine Task Force (under Janet Reno); and as
a member of the NIH Peer Review Oversight Group (under the Clinton
administration). Dr. Pentz received her B.A. in psychology from Hamilton
College and her Ph.D. in psychology from Syracuse University.
Tracy Stecker, Ph.D., is assistant professor at the Psychiatric Research
Center, Department of Community and Family Medicine, at Dartmouth
Medical School and a health services researcher at the White River Junc-
tion VA. Dr. Stecker is a psychologist and mental health services researcher
who focuses on help-seeking behavior in individuals with mental illness.
She has received funding from the National Institute of Mental Health to
develop and test cognitive-behavioral interventions designed to increase
mental health treatment seeking among veterans returning from the wars
in Iraq and Afghanistan, with a focus on those with symptoms of PTSD
OCR for page 388
388 SUBSTANCE USE DISORDERS IN THE U.S. ARMED FORCES
and suicidality. She has also received funding through the National Institute
on Alcohol Abuse and Alcoholism to assess whether these interventions
increase attendance at addiction treatment among individuals with alcohol
use disorders. Dr. Stecker received her Ph.D. degree from the University of
North Dakota, her M.A. degree from Austin Peay State University, and her
B.A. degree from Clemson University.
Constance Weisner, Dr.P.H., M.S.W., is associate director for health services
research at the Division of Research, Kaiser Permanente Medical Care Pro-
gram, Northern California, and professor in the Department of Psychiatry
at the University of California, San Francisco. She directs the Drug and
Alcohol Research Team, a large program of substance use research in Kaiser
Permanente. Dr. Weisner is a member of the World Health Organization’s
International Expert Advisory Council on Drug Dependence and Alcohol
Problems, and a former member of the National Advisory Council of the
National Institute on Drug Abuse and of the National Advisory Council
of the Center for Substance Abuse Treatment, Substance Abuse and Men-
tal Health Services Administration. Her research has been funded by the
National Institute on Alcohol Abuse and Alcoholism, the National Institute
on Drug Abuse, and the Robert Wood Johnson Foundation, and includes
the epidemiology of alcohol and drug problems and access to, outcomes of,
and cost impacts of substance use treatment. Dr. Weisner has served on sev-
eral IOM committees addressing topics related to mental health and addic-
tion, including the recent Committee on Improving the Quality of Health
Care for Mental and Substance Use Conditions. Dr. Weisner received her
doctorate in public health from the University of California, Berkeley, and
her M.S.W. from the University of Minnesota.
Institute of Medicine Staff
Maryjo M. Oster, Ph.D., is a program officer and study director at the
IOM. Prior to holding this position, she served as director of research
and evaluation at the Pennsylvania Coalition to Prevent Teen Pregnancy
(PCPTP), a statewide organization providing leadership on the issue of
adolescent pregnancy prevention through advocacy, education, and support
for community efforts. At PCPTP, she was the lead evaluator for a Centers
for Disease Control and Prevention–funded project to promote science-
based approaches to teen pregnancy prevention in schools and community
settings. Dr. Oster earned her Ph.D. in educational theory and policy from
The Pennsylvania State University. Research for her doctoral dissertation
investigated sex education policies across the state of Pennsylvania and
examined the social, political, and economic factors that influence the
design and adoption of these policies.
OCR for page 389
APPENDIX J 389
Emily C. Morden, M.S.W., is a research associate with the Board on the
Health of Select Populations at the IOM. Prior to working at IOM, she
interned in the U.S. Senate, researching issues ranging from international
trade relations to veteran health services. Before moving to Washington,
DC, Ms. Morden resided in Oregon and worked as a medical social worker
for a home hospice program. She has several years of experience working as
a residential counselor in both adult and adolescent mental health treatment
facilities for the largest community mental health care provider in the state
of Oregon. In this role, Ms. Morden gained expertise and clinical skills in
supporting clients in their recovery from mental illness. Ms. Morden holds
an M.S.W. degree from Portland State University and a bachelor’s degree
in sociology from the University of Oregon.
Jon Q. Sanders is a veteran program associate with the Board on the Health
of Select Populations at the IOM. He received his B.A. in anthropology with
a minor in geosciences from Trinity University and recently completed the
program management certification at George Mason University. In his 10
years with the National Academies, Mr. Sanders has worked on a variety of
projects on topics ranging from childhood obesity to national security. He is
coauthor of Sitting Down at the Table: Mediation and Resolution of Water
Conflicts (2001). His research interests include public health, emergency
management, and environmental decision making.
Frederick (Rick) Erdtmann, M.D., M.P.H., is a graduate of Bucknell Uni-
versity, where he received a B.S. degree in biology. He earned an M.P.H.
from the University of California, Berkeley. He attended Temple Univer-
sity School of Medicine in Philadelphia, where he earned his doctorate of
medicine. Dr. Erdtmann is board certified in preventive medicine. He spent
30 years as a commissioned officer in the U.S. Army Medical Department
with a variety of assignments, including chief of the Preventive Medicine
Services at Fitzsimons Army Medical Center, Frankfurt Army Medical
Center in Germany, and Madigan Army Medical Center. He also served
as division surgeon for the Second Infantry Division and as chief of the
P
reventive Medicine Consultant’s Division in the surgeon general’s office.
Dr. Erdtmann served as commander of Evans Army Community Hospital
from 1995 to 1997. He was deputy chief of staff for clinical operations
within TRICARE Region 1 prior to assuming Hospital Command at
Walter Reed Army Medical Center in March 1998. He then was assigned
to the Office of the Surgeon General as deputy assistant surgeon general
for force development. Following military retirement in 2001, Dr. Erdt-
mann joined the IOM. He currently serves as director of the Board on the
Health of Select Populations (formerly the Board on Military and Veterans
Health).
OCR for page 390
